Elite Pharmaceuticals Inc (ELTP): Weighted Average Diluted Shares
1.14B
Year ended 2026-03-31
+4.0%
3-year compound annual growth
+3.8%
5-year compound annual growth
+5.4%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | 1.14B | +6.6% | 2026-06-29, From 2025-04-01 |
| 2025-03-31 | 1.07B | +4.4% | 2026-06-29, From 2024-04-01 |
| 2024-03-31 | 1.02B | +1.0% | 2025-06-30, From 2023-04-01 |
| 2023-03-31 | 1.01B | +0.2% | 2024-07-01, From 2022-04-01 |
| 2022-03-31 | 1.01B | +7.2% | 2023-06-29, From 2021-04-01 |
| 2021-03-31 | 943.00M | -5.1% | 2022-06-29, From 2020-04-01 |
| 2020-03-31 | 993.26M | +21.7% | 2021-06-14, From 2019-04-01 |
| 2019-03-31 | 816.31M | +2.3% | 2020-06-29, From 2018-04-01 |
| 2018-03-31 | 798.17M | -5.5% | 2019-06-21, From 2017-04-01 |
| 2017-03-31 | 844.51M | +25.3% | 2018-06-14, From 2016-04-01 |
| 2016-03-31 | 673.91M | -11.0% | 2018-06-14, From 2015-04-01 |
| 2015-03-31 | 757.58M | +63.6% | 2017-06-14, From 2014-04-01 |
| 2014-03-31 | 463.02M | -12.1% | 2016-06-15, From 2013-04-01 |
| 2013-03-31 | 526.88M | n/c | 2014-06-30, From 2012-04-01 |
| 2012-03-31 | 259.16M | n/a | 2013-06-21, From 2011-04-01 |